Literature DB >> 19389846

Possible effects of the new Medicare reimbursement policy on African Americans with ESRD.

Areef Ishani1, Haifeng Guo, Thomas J Arneson, David T Gilbertson, Lih-Wen Mau, Suying Li, Stephan Dunning, Allan J Collins.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19389846      PMCID： PMC2709674          DOI： 10.1681/ASN.2008080853

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  17 in total

1.  Racial variations in erythropoietic response to epoetin alfa in chronic kidney disease and the impact of smoking.

Authors:  Charlotte Jones-Burton; Stephen L Seliger; Jeanine Brown; Lucy Stackiewicz; Van Doren Hsu; Jeffrey C Fink
Journal:  Nephrol Dial Transplant       Date:  2005-09-27       Impact factor: 5.992

2.  KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease.

Authors: 
Journal:  Am J Kidney Dis       Date:  2006-05       Impact factor: 8.860

3.  Anemia severity and missed dialysis treatments in erythropoietin-treated hemodialysis patients.

Authors:  O Ifudu; E Chan; H Paul; J D Mayers; L S Cohen; W F Brezsnyak; A I Herman; M M Avram; E A Friedman
Journal:  ASAIO J       Date:  1996 May-Jun       Impact factor: 2.872

Review 4.  Resolving the paradigm crisis in intravenous iron and erythropoietin management.

Authors:  A Besarab
Journal:  Kidney Int Suppl       Date:  2006-05       Impact factor: 10.545

5.  Hematologic differences between African-Americans and whites: the roles of iron deficiency and alpha-thalassemia on hemoglobin levels and mean corpuscular volume.

Authors:  Ernest Beutler; Carol West
Journal:  Blood       Date:  2005-03-24       Impact factor: 22.113

6.  Impact of quality improvement efforts on race and sex disparities in hemodialysis.

Authors:  Ashwini R Sehgal
Journal:  JAMA       Date:  2003-02-26       Impact factor: 56.272

7.  Trends in anemia at initiation of dialysis in the United States.

Authors:  G T Obrador; T Roberts; W L St Peter; E Frazier; B J Pereira; A J Collins
Journal:  Kidney Int       Date:  2001-11       Impact factor: 10.612

8.  Racial/ethnic analysis of selected intermediate outcomes for hemodialysis patients: results from the 1997 ESRD Core Indicators Project.

Authors:  D L Frankenfield; M V Rocco; P R Frederick; J Pugh; W M McClellan; W F Owen
Journal:  Am J Kidney Dis       Date:  1999-10       Impact factor: 8.860

9.  The association of race with erythropoietin dose in patients on long-term hemodialysis.

Authors:  Eduardo Lacson; John Rogus; Ming Teng; J Michael Lazarus; Raymond M Hakim
Journal:  Am J Kidney Dis       Date:  2008-09-27       Impact factor: 8.860

10.  Access to recombinant erythropoietin by Medicare-entitled dialysis patients in the first year after FDA approval.

Authors:  N R Powe; R I Griffiths; G de Lissovoy; G F Anderson; A J Watson; J W Greer; R J Herbert; P W Eggers; R A Milam; P K Whelton
Journal:  JAMA       Date:  1992-09-16       Impact factor: 56.272
View more
  7 in total

1.  Meeting KDOQI guideline goals at hemodialysis initiation and survival during the first year.

Authors:  Yelena Slinin; Haifeng Guo; David T Gilbertson; Lih-Wen Mau; Kristine Ensrud; Thomas Rector; Allan J Collins; Areef Ishani
Journal:  Clin J Am Soc Nephrol       Date:  2010-06-10       Impact factor: 8.237

2.  Variant hemoglobin phenotypes may account for differential erythropoiesis-stimulating agent dosing in African-American hemodialysis patients.

Authors:  Vimal K Derebail; Patrick H Nachman; Nigel S Key; Heather Ansede; Ronald J Falk; Wayne D Rosamond; Abhijit V Kshirsagar
Journal:  Kidney Int       Date:  2011-08-17       Impact factor: 10.612

3.  Has dialysis payment reform led to initial racial disparities in anemia and mineral metabolism management?

Authors:  Marc N Turenne; Elizabeth L Cope; Shannon Porenta; Purna Mukhopadhyay; Douglas S Fuller; Jeffrey M Pearson; Claudia Dahlerus; Brett Lantz; Francesca Tentori; Bruce M Robinson
Journal:  J Am Soc Nephrol       Date:  2014-10-09       Impact factor: 10.121

4.  Variation in dialysis quality measures by facility, neighborhood, and region.

Authors:  Milda R Saunders; Marshall H Chin
Journal:  Med Care       Date:  2013-05       Impact factor: 2.983

5.  An open-label, sequential, dose-finding study of peginesatide for the maintenance treatment of anemia in chronic hemodialysis patients.

Authors:  Anatole Besarab; Steven N Zeig; Edouard R Martin; Pablo E Pergola; Frederick C Whittier; Raja I Zabaneh; Brigitte Schiller; Martha Mayo; Carol A Francisco; Krishna R Polu; Anne-Marie Duliege
Journal:  BMC Nephrol       Date:  2012-08-30       Impact factor: 2.388

6.  Comparative changes in treatment practices and clinical outcomes following implementation of a prospective payment system: the STEPPS study.

Authors:  Keri L Monda; Parveen Nedra Joseph; Peter J Neumann; Brian D Bradbury; Robert J Rubin
Journal:  BMC Nephrol       Date:  2015-05-01       Impact factor: 2.388

7.  The economic considerations of patients and caregivers in choice of dialysis modality.

Authors:  Rachael C Walker; Kirsten Howard; Allison Tong; Suetonia C Palmer; Mark R Marshall; Rachael L Morton
Journal:  Hemodial Int       Date:  2016-05-15       Impact factor: 1.812
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.